1,615
Views
5
CrossRef citations to date
0
Altmetric
Review

Chronic Obstructive Pulmonary Disease and its Non-Smoking Risk Factors in India

, &

Abstract

The rising prevalence of the chronic obstructive pulmonary disease (COPD) is generally attributed to smoking, since the role of other risk factors among non-smokers are not well established especially in low and middle income countries like India. This is also reflected by the limited literature available on non-smoking related COPD risk factors like indoor and outdoor air pollution. The present review is an attempt to assess the influence of non-smoking risk factors on COPD and its measures in Indian subcontinent. The most noteworthy factors among non-smokers appear to be the use of biomass fuel for cooking and heating purposes. We observed that the studies undertaken to evaluate the role of such risk factors are inconclusive due to weak methodologies and small sample sizes, may be due to limited financial resources. The present review suggests the need of a nationally representative study to estimate the effect of each of the potential modifiable risk factor (other than smoking) for framing impactful public health policies to prevent and manage COPD at community and population level in India.

Introduction

Chronic obstructive pulmonary disease (COPD) is a disease state characterized by persistent airflow limitation that is usually progressive and is associated with enhanced chronic inflammatory response in the airways to noxious particles or gasses (Citation1). COPD symptoms include dyspenea, chronic cough and sputum production. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition of COPD does not include patient-reported, physician-diagnosed chronic bronchitis and emphysema, as they can be present in individuals with normal lung function (Citation1).

COPD is a multifactorial complex disease, considerably influenced by interaction of genetic and environmental risk factors (Citation2). Tobacco smoking has been considered as the leading cause underlying rising prevalence of COPD across the globe (Citation3, Citation4). Majority of COPD prevalence surveys and clinical trials were based on participants who smoke or have history of tobacco smoking (Citation3, Citation4). This in turn has over shadowed the importance of other lifestyle and environmental risk factors (Citation5). Recent evidences suggest that non-smoking related COPD is higher than previously believed, particularly in the low and middle income countries (LMICs), accounting for 1/4th to 1/3rd of all COPD cases (Citation6).

Globally, a noticeable proportion of COPD cases are known to be non-smokers, ranging from 22.9% in UK (Citation6) to 47% in South Africa (Citation5). In India specifically, 69% of COPD cases were found to be never smokers in a study conducted on 1200 slum dwellers in Pune, Maharashtra (Citation7). In another ­setting, the overall prevalence of COPD was found to be 2.44% (95%CI = 1.43–3.45) among non-smoking women of Tiruvallur district of Tamilnadu in south India (Citation8).

Several risk factors (apart from smoking) have been identified in various studies conducted both globally (Citation5, Citation6, Citation9) and in India (Citation10, Citation11). Large proportion of the women in developing countries, as compared to developed countries, is exposed to biomass fuel that cause non-smoking related COPD. Further, COPD is influenced by occupation based lifestyle factors (like dust, fumes, smoke and other pollutants) commonly present in LMICs, including India (Citation12).

At present, there is not a single nationally representative study that assessed the non-smoking related risk of COPD in India. However, there are studies available for selected geographical locations across India that had evaluated variety of non-smoking related risk factors of COPD (Citation8, Citation10, Citation13). Hence, a review to evaluate each non-smoking risk factor of COPD and to identify high risk population groups would help in understanding the magnitude of the problem. This will further help in designing necessary public health policy to prevent and manage COPD among the target population groups. Keeping the above in mind, the present review was aimed to gather all the available evidence for each of the risk factor (other than smoking) reported to be associated with COPD in Indian subcontinent.

Epidemiological burden

COPD is one of the top five causes of mortality with 2.9 million deaths and was ranked 9th (approximately 7.67 million) in the loss of disability adjusted life years (DALYs) in 2010 (Citation14). According to world health statistics, COPD is expected to be the third leading cause of deaths by 2030 (Citation15) of which almost 90% of COPD deaths occur in LMICs (Citation16). In South Asia, COPD was ranked 5th in causing both mortality and loss of DALYs in 2010 (Citation14). In 1996, the estimated  burden of COPD in India was over 12 million, based  on several studies sponsored by the Indian  Council of Medical Research (ICMR), involving 35,295 adults of age >35 years. (Citation10). In 2004, the age-standardized death rate due to COPD in India was 102.3 per 100,000 amongst both sexes (Citation17), which would translate to 556,000 COPD cases (Citation18). However, the epidemiological data currently available for India is still thin and underestimate the total burden of COPD.

Salvi and his colleagues have summarized the various challenges in determining true prevalence of COPD in population studies (Citation19). There are great variations in the reported morbidity, which could partly be due to differences in the definition of a ‘case’ (Citation20). COPD is often wrongly described by its prototype chronic bronchitis in most epidemiological studies (Citation21). For instance, Tan and Ng (Citation22) reported 6.3% COPD prevalence in Asia-Pacific region compared to 3.9% World Health Organization (WHO) estimate (Citation19). Thus, it is sometimes difficult to accumulate and compare the findings of prevalence and risk factors of chronic bronchitis along with that of COPD, as done in several Indian studies (Citation23–32). Further, diagnosis of COPD based on GOLD guidelines (Citation1) involves lung function measures, important ones being forced vital capacity (FVC) and forced expiratory volume in 1st second (FEV1).

These are assessed by pre and post bronchodilator spirometry which is not easy to perform in poorly resourced population based epidemiological studies (Citation33, Citation34). Thus, COPD often remains underreported in LMICs (Citation35). Moreover, recently the issues with considering of defining COPD (FEV1/FVC < 0.7) and grading its severity (FEV1 < 80% predicted) according to GOLD guidelines (Citation1) have been discussed (Citation36, Citation37). It has been pointed out that the use of fixed FEV1/FVC ratio introduces significant age and gender bias that can result in under-diagnosis in young adults and over-diagnosis in elderly adults, especially in East Asians (Citation37).

Similarly, % predicted FEV1 value is highly dependent on an individual's age and thus the severity of the airway obstruction or lung deterioration could be misclassified, especially in elderly population (Citation37). The use of forced expiratory flow at 25–75% of FVC (FEF25-75%) or flow when 75% of FVC has been exhaled (FEF75%) by clinicians for decision making has also been discouraged as discordance has been reported while using these measures compared to standard use of FEV1/FVC and FEV1 values as airways obstruction can go undetected in upto 2.9% cases by FEF25-75% and 12.3% cases by FEF75% (Citation38).

The mortality data also underestimates COPD as a cause of death because the disease is more likely to be cited as a contributory rather than an underlying cause of death, or may not be cited at all (Citation39). Depending on the severity of the disease, the 5-year mortality rate for patients with COPD varies from 40% to 70%. A recent systematic review suggests the prevalence of chronic bronchitis to lie between 6.5–7.7% in rural India, but accurate general prevalence of COPD / chronic bronchitis across Indian subcontinent still remains unpredicted (Citation40). In addition, the commonly associated co-morbidities related to COPD like cardiovascular disease, lung cancer, osteoporosis and diabetes are increasing the epidemiological burden by several folds (Citation41).

Although the prevalence rates are available in 10 out of 28 Indian states but heterogeneity in study design and quality makes it difficult to assess the national prevalence of COPD. Moreover, because of paucity of data and inconsistency in the study settings, estimating the general prevalence rate of COPD in India remains a challenge where specific population characteristics persist (Citation40). According to small prevalence studies conducted across India (Table ), the median prevalence rates are 5.5% for males and 3.2% for females. Thus, clearly COPD is more common among males than females that can be contributed to the associated lifestyle factors like smoking and occupational hazards. The male to female ratio varied from 1.32:1 to 2.6:1 with median ratio of 1.6:1.5 (Citation42). However, these studies were confined to limited areas and do not represent the general population of that state or region.

Table 1. Prevalence of COPD in Indian states

Risk factors

The most common risk factor of COPD worldwide is tobacco smoking (Citation21, Citation50Citation54). According to series of studies initiated by ICMR (INSEARCH-I) in India, smokers had 3 times more risk of developing COPD as compared to non-smokers (Citation10). Further, among smokers, bidi smokers were at a higher risk of developing COPD (8.2%) than the cigarette smokers (5.9%) (Citation55). However, numerous other non-modifiable (age, gender and genetic factors) and modifiable factors (indoor and outdoor air pollution, exposure to environmental tobacco smoke and occupational dust and chemicals) have also been identified as potential risk factors of COPD among non-smokers worldwide (Citation5, Citation6) including India (Citation17). In addition, diet, long standing asthma, recurrent respiratory infection in early childhood and tuberculosis are also known to play a role in development of COPD among non-smokers (Citation6). Briefly, the risk of developing COPD is related to the total burden of inhaled particles that an individual encounters over the life time through above mentioned exposures and to any other factor that effect their lung growth during gestation and childhood such as low birth weight and respiratory infections (Citation1).

Salvi and Barnes (Citation5) efficiently gathered the evidences of non-smoking risk factors of COPD dating back to 1963 which included environmental (Citation56) and ­occupational exposures (Citation57). According to WHO statistics, the causes for COPD have opposite patterns according to the geographic areas (Citation58). In high- and middle-income countries, tobacco smoke is the biggest risk factor (Citation3). In contrast, exposure to indoor air pollution like biomass fuel due to cooking and heating purposes in low-income settings, specifically Asian countries, is causing COPD burden (Citation59) along with outdoor air pollution and poor socio-economic status (Citation6). The summary of studies evaluating the risk factors associated with COPD in Indian population is summarized in

Table 2. COPD non-smoking risk factors evaluated in India

Indoor air pollution

The principal sources of indoor air pollutants that are related to development of COPD include smoke produced by domestic use of different cooking fuels and environmental tobacco smoke or passive smoke (Citation60, Citation61). The available evidence shows that comparatively low birth weight babies are born to women exposed to biomass smoke from open fires (Citation62) and environmental tobacco smoke (Citation63). The outcome of low birth weight is an independent risk factor of COPD associated with poor lung growth and lung function during childhood and adulthood (Citation64).

Domestic fuel

Around 50% of the world's population (about 2.4 billion people) uses biomass fuel as the primary energy source and almost 2 million deaths per year are attributable to solid fuel use, with more than 99% of these occurring in developing countries (Citation6, Citation11, Citation65, Citation66). Indoor air pollution from solid fuel use in developing countries was estimated to account for about 1.6 million deaths annually in 2004 and about 500,000 in India in 2010, suggesting a serious impact on health (Citation67, Citation68). An odds of 2.3 (CI = 1.5–3.5) for COPD has been seen with exposure to biomass smoke in a meta analysis of 36 global studies (Citation69). Further, 400–550,000 prematured deaths and 4–6% of Indian National burden of disease has been attributed to annual use of biomass fuel and indoor air pollution respectively (Citation62).

Indoor exposure to domestic fuel combustion, especially biomass fuel, is reported to be an important cause of chronic bronchitis and COPD in females in studies from India, Nepal, China, South Africa, Turkey, etc. (Citation70Citation76). It has been argued that the exposure to biomass fuel has larger risk for COPD than tobacco smoking (Citation11). It has also been suggested that the women with domestic exposure to combustion of biomass fuel may develop COPD with clinical characteristics and have impaired quality of life with increased mortality similar in extent to those of the tobacco smokers (Citation77). Women exposed to biomass smoke are even reported to have more local scarring and pigment deposition in the lung parenchyma and fibrosis in the small airway wall (Citation78).

In a large study of 3608 nonsmoking Indian women involved in domestic cooking, 13% participants reported respiratory symptoms (Citation79). Further, increased prevalence of COPD-related respiratory symptoms and deteriorated lung function have been reported among Indian women using biomass fuel for cooking compared to controls (Citation80, Citation81).

In rural areas of developing countries, biomass fuel burning is often carried out in indoor environment with open fire using poorly functioning stoves with limited ventilation facilities (Citation61). Due to socio-cultural reasons, rural Indian women are exposed to fuels for 30-40 years throughout their life equivalent to ~60,000 hours, starting from a very early age in an enclosed space with poor ventillatory facilities and seasonal variations (Citation80). The common type of cooking devices used are ­kerosene stoves (wick type or pressure type), coal lighted angithi, gas stoves operated with liquid petroleum gas (LPG) and chullas in which biomass fuels are used (Citation80). Biomass fuel usually involves wood, crop residues and animal dung whose burning emits a variety of toxins due to their low combustion efficiency.

It is estimated that biomass fuel is used in over 70% of Indian homes for cooking and heating purposes (Citation59). Further, 90% of rural and 32% of urban households use biomass stoves for cooking purpose (Citation82). In rural India, 62% of households use firewood and 14% cook with dung cakes while 13% use straw, shrubs, grass and agricultural crop residues to fire their stoves. In urban India, 22% use firewood, 8% use kerosene and the rest uses cleaner fuels such as LPG or natural gas (Citation83) for cooking and heating purpose.

Biomass smoke contains a large number of pollutants including ambient particulate matter of less than 10 μm in aerodynamic diameter (PM10), carbon monoxide, nitrogen dioxide, sulfur dioxide, formaldehyde, asbestos fibers, microorganisms, allergens and polycyclic organic matter, including carcinogens (Citation84, Citation85). WHO safety standards specify that the PM10 concentration is 150 μg/m3 in 24 hours (Citation5). Environment Protection Agency (EPA) safety standards specify that the carbon monoxide concentration should be no more than 10 ppm in 8 hours (Citation5). However, burning of biomass fuel generates a mean concentration of 300–3000 μg /m3 PM10 in 24 hours and concentrations of 30,000 μg/m3 can be reached during cooking periods depending on the type of fuel, ventilation and duration of combustion (Citation86). In homes using biomass fuel, concentration of carbon monoxide can be 2–50 parts per million (ppm) in 24 hours and 10–500 ppm during cooking (Citation63).

Evidence from south Indian states inform that the concentration of respirable particulate matter (RPM) ranges from 500–2000 μg/m3 during cooking with biomass fuel in households, which on 24 hours’ of exposure ranged from 90 ± 21 μg/m3 for those not involved in cooking to 231 ± 109 μg/m3 for those who cooked in Tamil Nadu (Citation87). In Andhra Pradesh, the mean 24 hours’ average concentrations ranged from 73–732 μg/m3 in gas versus 80–573 μg/m3 solid fuel using households, respectively (Citation88).

Even among biomass fuels the severity of pollutants varies. For instance, benzene concentration in indoor kitchen using wood fuel was found to be significantly lower (p < 0.01) in comparison to dung fuel used in variety of Indian kitchen facilities (Citation89, Citation90). Indoor mean concentrations of PM2.5 and associated Poly Aromatic Hydrocarbon (PAH) during cooking ranges from 1.19 ± 2.29 to 2.38 ± 0.35 μg/m3 among biomass fuel users and 6.21 ± 1.54 to 12.43 ± 1.15 μg/m3 among plant material users in rural north Indian homes. Similarly, PM10 and total PAH ranges from 3.95 ± 1.21 to 8.81 ± 0.78 μg/m3 and 7.75 ± 1.42 to 15.77 ± 1.05 μg/m3, respectively (Citation91).

The blood carboxy hemoglobin concentrations in non-smoking healthy females from Chandigarh and its adjoining areas in India exposed to different types of cooking fuel were 2-5 times significantly higher than those in non-smoking healthy unexposed females (who had not done any cooking seven days prior to investigation) (Citation84). The observed carboxy hemoglobin values were 7.52% (0.67%) for kerosene, 15.74% (0.83%) for biomass fuel and 17.16% (0.62%) for liquid petroleum gas, compared with 3.52% (0.33%) in the control subjects (Citation84).

The FVC values are reported to be the worst in biomass and mixed fuel users as compared to other groups, for instance, a negative correlation between lung function, cooking duration and exposure index, was reported among rural Indian women (Citation80). The Pondicherry urban slums of India using biofuels experienced more respiratory symptoms (23%) than those using kerosene (13%; p > 0.05) or LPG (8%; p < 0.05). Moreover, the values of lung function were significantly lower in biofuel users compared with both kerosene (p < 0.01) and LPG users (p < 0.001) (Citation81). Further, COPD prevalence was higher in biomass fuel users than the clean fuel users 2.5 vs. 2% (Table ) and it was two times higher (3%) in women who spend >2 hours/day in kitchen while cooking in Tamil Nadu, India (Citation8).

Interestingly, a cytogenetic analysis (micronucleus and chromosomal aberration) have reported higher frequency of DNA damage in biomass fuel users exposed for > 5 years compared to LPG in Indian women (Citation92). A minimum required biomass exposure index of 60 has been identified which is significantly associated with chronic bronchitis after adjusting for age, passive smoking and occupational exposure. In the district of Mysore in Karnataka state of India, it was observed that one in every 20 non-smoking women having biomass fuel exposure index of ≥110 develops chronic bronchitis (Citation93).

The heavy dependency on the use of biomass fuel in rural parts of India is due its negligible cost, high availability and its involvement in the socio-cultural milieu of people's life from centuries. Thus, taking biomass fuel out of people's life will be a challenge, but we can certainly explore the possibilities to avoid its exposure. Therefore, India needs to develop a policy for separate kitchen on the lines of separate toilets for hygiene, with proper ventilation and promote the use of chimneys for both cooking and heating purposes.

Environmental tobacco smoke exposure

Passive smoke or environmental tobacco smoke exposure among non-smokers, especially in women and children, is very common in Asian countries including India (Citation94). Among over 7000 chemicals identified in second hand tobacco smoke, at least 250 of them are known to be harmful (Citation61). Parental smoking is reported to result in significant decline in FEV1 among children (Citation94, Citation95). The additional exposure to second hand smoke has been reported to further increase the prevalence of COPD among biomass fuel users (3.9% in biomass fuel users and 4.8% in addition of regular passive smoking) in rural areas of southern India in Mysore (Citation49).

Outdoor Air Pollution

The evidences from both longitudinal and cross sectional studies support the association of high concentration of outdoor air pollutants with COPD exacerbation and worsening of pre-existing COPD (Citation96Citation99). Air pollution has been consistently increasing in developing countries attributable to industrialization and traffic congestion, specifically in Asia (Citation100). This has raised the gaseous and particulate matter component concentrations of urban ambient air which is associated with increasing respiratory morbidity (Citation101). Moreover, strong evidence exists for adverse effects of outdoor and traffic-related air pollution on lung development in children (Citation97, Citation98). The deleterious effects of particulate pollutants, such as ozone and nitrogen-dioxide, on airway are also known, such as, increase in bronchial reactivity (Citation102), airway oxidative stress (Citation103), pulmonary and systemic inflammation (Citation104, Citation105), amplification of viral infections (Citation106) and reduction in airway cilliary activity (Citation107).

India is listed as heavily polluted along with other South Asian countries in a global air pollution survey conducted by WHO (Citation108), where 13 out of 20 most polluted cities were from India. Studies conducted in capital city, Delhi, showed comparatively higher prevalence of respiratory symptoms in its higher pollution zones (Citation72) and an increase of 24.9% in emergency room visits for COPD due to higher levels of outdoor pollutants (Citation109). Suspended particulate matter (SPM) together with relative humidity were found to explain 33% variability in COPD in Delhi during the assessment of hospital admissions attributed to respiratory morbidity from 2000–2003 (Citation13) and significant correlations were reported for various pollutants (see Table ). A couple of studies have also been reported from Mumbai, another metropolitan city of India, presenting the high prevalence of COPD (Citation110) and the health expenditure burden attributable to air pollution (Citation111).

The outdoor air pollution in Indian cities is difficult to control, due to their large population size, constantly increasing population density of cities, the rising needs for livelihood of people and high sentiments attached to sociocultural activities. The role of Indian government is extremely important at least in gradually transforming unplanned cities to planned cities keeping public health as major criteria for restructuring the urban landscape. In addition, India needs a policy on migration for restricting the constantly expanding city area by developing facilities compatible to the aspiring rural India.

Occupational Hazards

There is an established relationship between COPD and occupational exposure to toxic gases at workplace (Citation112), grain dust in farms (Citation57) and dust or fumes in factories (Citation113). Occupational agents may act similar to smoking, requiring other promoting factors before an effect is seen (Citation114).

India is the largest producer of pesticides in Asia and is third largest consumer in the world (Citation115), which overall affects the respiratory health of the population. COPD prevalence has been seen higher (p < 0.001) among agricultural workers spraying cholinesterase-inhibition pesticides (18.1%) compared to controls (6.9%) in Eastern India (Citation116). Further, 22% of farm laborers and 31% of cotton/jute workers were found to have deteriorated lung function (FEV1/FVC < 0.7) in a study conducted in West Bengal (Citation117). High prevalence of chronic bronchitis in different sub-occupational groups of brassware workers (Citation118) and ventillary dysfunction among glass bangle workers (Citation119) have also been reported in India. The long term exposure of metal dust was evaluated among metal polish workers in 25 brass and steel ware polishing industries at Moradabad and unexposed controls in North India, where 6.7% of polishers were found to have chronic bronchitis (Citation120). A total of 58.6% polishers had one or more respiratory symptoms like chronic cough and chronic phlegm compared to only 25.5% of the controls (p < 0.05). In addition, the polishers exhibited significantly greater reductions in lung function over the work shift (Citation120). A higher prevalence of chronic bronchitis has also been seen among railway workers (16.7%) compared to controls (8.9%) in India; as the peak expiratory flow rate <300L/min was observed in 54.6% railway workers compared to only 2.2% in controls (Citation121).

Thus, the exposure to occupational factors has serious ill respiratory effects on the health of workers that requires government policy ensuring the healthy working environment in Indian factories.

Socio-Economic Position

The differences in socio-economic position (SEP) is also reported to be correlated with lung function (Citation122). The factors related to poor SEP plays important role in the development of COPD which includes poor dietary habits involving low consumption of fresh fruits while consuming food items having low anti-oxidants (Citation123), poor housing conditions (Citation124) and relatively more exposure of occupational dust and indoor air pollution from biomass combustion (Citation125). These poor living conditions are also related to intra-uterine growth retardation, childhood respiratory tract infection, exposure to tobacco smoke, biomass smoke and other indoor air pollutants and occupational risks (Citation5).

The research gap in exploring the differences in the prevalence of COPD in various socioeconomic groups needs to be addressed in India as well, where there is a huge problem of inequity.

Other Risk Factors

Male sex and increasing age are well established non-modifiable risk factors of COPD (Citation21, Citation52, Citation54, Citation126). Apart from smoking, this relationship could be attributed to greater exposure to environmental and occupational pollutants among men and the cumulative effect of all risk factors with advancing age. Jain et al. (Citation127) summarized the gender-related differences existing in COPD patients in India that included an early age of onset in females compared to males (mean age of 58.34 ± 9.99 years v/s 61.57 ± 10.37 years, p < 0.001). Females represented more dyspenea at presentation (grade 3 v/s grade 2, p < 0.001) which could be explained by relatively more bronchial obstruction (mean FEV1 of 43.39 ± 13.28 v/s 48.42 ± 14.52, p < 0.001), more exaceberations and higher prevalence of systemic features (Citation127).

The difference in body mass index (BMI) is also reported to be associated with the development of COPD. For instance, a hospital based study found that 83% of COPD patients were found to have BMI < 18 kg/m2 in the city of Luknow in North India (Citation128). However, the loss of body weight can also be a consequence rather than a risk factor of progression of the disease as BMI was found to be negatively correlated with duration of hospital stay (r = –0.0103, p = 0.03) (Citation128). The positive correlation between oxidative stress and BMI in COPD status and predicted % of FEV1 has also been reported. COPD patients were found to have increased plasma lipid peroxidation ( p = 0.006) and decreased antioxidant glutathione ( p = 0.005), glutathione peroxidase ( p = 0035) and catalase activity ( p = 0.008) in another Indian study and all these markers were found to be correlated with BMI of the patients (Citation129).

History of pulmonary tuberculosis has been reported to be a strong predictor of COPD (Citation130). This infection is associated with airway fibrosis and the immune response to mycobacteria which can result in airway inflammation, a characteristic of COPD (Citation5). Similarly, chronic asthma is reported to cause lung remodeling (Citation131) resulting in irreversible and progressive airflow obstruction and development of COPD that are similar to those resulting from smoking (Citation132). However, treatment of asthma with corticosteroid helps in preventing irreversible airflow obstruction (Citation133). The literature on such conditions is lacking from India but some evidence points towards the relationship between COPD and arsenicosis (chronic arsenic toxicity) resulting from consuming contaminated ground water in West Bengal region on India (Citation134).

In last five years, due to the advent of genome-wide association studies (Citation135–137), the genetics of COPD has moved beyond α-1 antitrypsin gene (Citation138–142). Several genetic variants are reported to be associated with COPD in Indian population namely PIM3 allele of alpha-1-antitrypsin gene (Citation143), GSTT1, GSTM1 and GSTM3 (Citation144, Citation145), PiZ and Pi S (Citation146), cytokine gene polymorphisms (IL1B, IL1RN, TNF-α, and IL4) (Citation144), CYP2E1 and NAT2 (Citation147), GSTP1 and mEPHX (Citation148), COX2 and p53 (Citation149), CYP1A1, CYP1A2, and CYBA (Citation150), TIMP-1 and α1AT (Citation151). Our group is running “COPD genetics Consortium,” in collaboration with leading hospitals in North and West India, which aims to understand genetic predisposition to COPD in India, funded by Department of Biotechnology, Government of India.

Conclusion

The available data suggest that a number of modifiable risk factors other than smoking are apparently associated with COPD in India, the most important being the use of biomass fuel. However, the lack of strong evidences demands the need of conducting a nationally representative study with appropriate methodology to estimate the effect size of each of the potential risk factor (other than smoking) that can then help in framing health policies to prevent and manage COPD in Indian population. India should develop a consortium of clinicians, epidemiologists and biological anthropologists for planning population based nation-wide study to estimate prevalence and incidence of COPD and identify significant modifiable risk factors associated with it. Such studies should use well established universal definitions and validated diagnostic criteria and procedure for measuring various risk factors. The future study design for this work may consider exposures like rural vs. urban divide, geographic or ecological variation, socio-economic inequality and ethnic diversity in Indian population.

Declaration of Interest Statement

We declare that the authors of the manuscript have no conflict of interest. The authors alone are responsible for the content and writing of the paper.

Funding

We are thankful to Wellcome Trust, UK, for support and Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India for funding “COPD Genetics Consortium” project.

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org ( Accessed on 12th December 2012).
  • Gupta V, Ebrahim S. Genomics of Chronic Obstructive Pulmonary Disease. In: Jindal SK, Vijayan VK (Eds.). World Clinics Pulmonary and Critical Care Medicine. Chronic Obstructive Pulmonary Disease. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd. 2013; 2:55–71.
  • Chhabra SK, Rajpal S, Gupta R. Patterns of smoking in Delhi and comparison of chronic respiratory morbidity among beedi and cigarette smokers. Ind J Chest Dis Allied Sci 2001; 43:19–26.
  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1: 1645–1648.
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374:733–743.
  • Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology 2012; 17:908–912.
  • Brashier BB, Londhe JD, Jantikar AM, et al. Proceedings of the Annual World Congress of the European Respiratory Society: ERS 2005, Copenhagen. Prevalence of obstructive lung diseases in 12,043 urban slum dwellers of Pune City, India. ERS. Copenhagen. Session 351, Epidemiology of COPD. Poster No. 3787, 2005.
  • Johnson P, Balakrishnan K, Ramaswamy P, et al. Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion. Glob Health Action 2011; 4:7226.
  • Yin P, Zhang M, Li Y, et al. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health 2011; 11:586.
  • Jindal SK, Aggarwal AN, Chaudhary K, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Ind J Chest Dis Allied Sci 2006; 48:23–29.
  • Kodgule R, Salvi S. Exposure to biomass smoke as a cause for airway disease in women and children. Curr Opin Allergy Clin Immunol 2012; 12:82–90.
  • Sharma M, Majumdar PK, Occupational lifestyle diseases: An emerging issue. Ind J Occup Environ Med 2009; 13:109–112.
  • Agarwal R, Jayaraman G, Anand S, Marimuthu P. Assessing respiratory morbidity through pollution status and meteorological conditions for Delhi. Environ Monit Assess 2006; 114:489–504.
  • Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197–2223.
  • World Health Organization (WHO). World Health Statistics. Geneva: World Health Organization, 2008.
  • Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27:397–412.
  • World Health Organization. WHO Global Infobase on 10th March 2012. ( Updated as on 20/01/2011). Available from: https://apps.who.int/infobase/Index.aspx ( Accessed on 8th July 2012).
  • Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747–1757.
  • Salvi SS, Manap R, Beasley R. Understanding the true burden of COPD: the epidemiological challenges. Prim Care Respir J 2012; 21:249–251.
  • Tzanakis N, Anagnostopoulou U, Filaditaki V, et al. Prevalence of COPD in Greece. Chest 2004; 125:892–900.
  • Jindal SK. Emergence of chronic obstructive pulmonary disease as an epidemic in India. Ind J Med Res 2006; 124:619–630.
  • Tan WC, Ng TP. COPD in Asia: where East meets West. Chest 2008; 133:517–527.
  • Pande JN, Khilnani GC. Epidemiology and aetiology. In: Shankar PS (Eds.). Chronic obstructive pulmonary disease. Mumbai, India: Indian College of Physicians, 1997.
  • Nigam P, Verma BL, Srivastava RN. Chronic bronchitis in an Indian rural community. J Assoc Physicians India 1982; 30:277–280.
  • Thiruvengadam KV, Raghva TP, Bhardwaj KV. Survey of prevalence of chronic bronchitis in Madras city. In: Viswanath R, Jaggi OP (Eds.). Advances in chronic obstructive lung disease. Delhi: Asthma and Bronchitis Foundation of India, 1977.
  • Joshi RC, Madan RN, Brash AA Prevalence of chronic bronchitis in an industrial population in North India. Thorax 1975; 30:61–67.
  • Malik SK, Kashyap S. Chronic bronchitis in rural hills of Himachal Pradesh, northern India. Ind J Chest Dis Allied Sci 1986; 28:70–75.
  • Radha TG, Gupta CK, Singh A, Mathur N. Chronic bronchitis in an urban locality of New Delhi–an epidemiological survey. Ind J Med Res 1977; 66:273–85.
  • Bhattacharyya SN, Bhatnagar JK, Kumar S, Jain PC. Chronic bronchitis in rural population. Ind J Chest Dis 1975; 17:1–7.
  • Akhtar MA, Latif PA. Prevalence of chronic bronchitis in urban population of Kashmir. J Ind Med Assoc 1999; 97:365–366, 369.
  • Malik SK. Profile of chronic bronchitis in North India: The PGI experience (1972-1985). Lung India 1986; 4:89–100.
  • Viswanathan R, Singh K. Chronic bronchitis and asthma in urban and rural Delhi. In: Viswanathan R, Jaggi OP (Eds.). Advances in chronic obstructive lung disease. Delhi: Asthma and Bronchitis Foundation of India. 1977; 44–58.
  • Rennard SI. COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 1998; 113:235S–241S.
  • Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Res Crit Care Med 2001; 163:1256–1276.
  • Udwadia ZF. The burden of undiagnosed airflow obstruction in India. J Assoc Physicians India 2007; 55:547–548.
  • Miller MR. Does the use of per cent of predicted have any evidence base? Eur Respir J 2015; 45:322–323.
  • Quanjer PH, Cooper B, Ruppel GL, et al. Defining airflow obstruction. Eur Respir J 2015; 45:561–562.
  • Quanjer PH, Weiner DJ, Pretto JJ, et al. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J 2014; 43:1051–1058.
  • Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156:814–8.
  • McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: a systematic review. Prim Care Respir J 2012; 21:313–321.
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341–1351.
  • Jindal SK, Aggarwal AN, Gupta D. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking. Ind J Chest Dis Allied Sci 2001; 43:139–147.
  • Wig KL, Guleria JS, Bhasin RC, et al. Certain clinical and epidemiological patterns of chronic obstructive lung disease as seen in Northern India. Ind J Chest Dis 1964; 6:183–194.
  • Sikand BK, Pamra SP, GP M. Chronic bronchitis in Delhi as revealed by mass survey. Ind J Tub 1966; 13:94–101.
  • Viswanathan R, Prashad M, Thakur A. Epidemiology of chronic bronchitis: Morbidity survey in Patna urban area. Ind J Med Res 1966; 54:11.
  • Charan N. Chronic bronchitis in north India, Punjab. In: Viswanathan OJR (Ed.). Advances in Chronic Obstructive Lung Disease. Delhi: Asthma and Bronchitis Foundation of India. 1977; 92–102.
  • Jindal SK. A field study on follow up at 10 years of prevalence of chronic obstructive pulmonary disease &#38; peak expiratory flow rate. Ind J Med Res 1993; 98:20–26.
  • Ray D, Abel R, Selvaraj KG. A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Ind J Med Res 1995; 101:238–244.
  • Mahesh PA, Jayaraj BS, Prahlad ST, et al. Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore: A pilot study. Lung India 2009; 26:63–69.
  • Chan-Yeung M, Aït-Khaled N, White N, et al. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis 2004; 8:2–14.
  • Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8:17–21.
  • Kim DS, Kim YS, Jung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005; 172:842–847.
  • Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9:458–465.
  • Maranetra KN, Chuyaochoo B, Dejsomritrutai W, et al. The prevalence and incidence of COPD among urban older persons of Bangkok Metropolis. J Med Assoc Thai 2002; 85:1147–1155.
  • Bhome AB. COPD in India: Iceberg or volcano? J Thorac Dis 2012; 4:298–309.
  • Phillips AM. The influence of environmental factors in chronic bronchitis. J Occup Med 1963; 5:468–475.
  • Husman K, KoskenvuoM, KaprioJ, et al. Role of environment in the development of chronic bronchitis. Eur J Respir Dis Suppl 1987; 152:57–63.
  • World Health Organization. Causes of COPD. Geneva: World Health Organization. Available from: http://www.who.int/respiratory/copd/causes/en/ ( Accessed on 13th November 2013).
  • Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010; 138:3–6.
  • Behera D, Sood P, Singh S. Passive smoking, domestic fuels and lung function in north Indian children. Ind J Chest Dis Allied Sci 1998; 40:89–98.
  • Ko FW, Hui DS. Air pollution and chronic obstructive pulmonary disease. Respirology 2012; 17:395–401.
  • Smith KR. National burden of disease in India from indoor air pollution. Proc Natl Acad Sci U S A 2000; 97:13286–13293.
  • Boy E, Bruce N, Delgado H. Birth weight and exposure to kitchen wood smoke during pregnancy in rural Guatemala. Environ Health Perspect 2002; 110:109–114.
  • Hancox RJ, Poulton R, GreeneJM, et al. Associations between birth weight, early childhood weight gain and adult lung function. Thorax 2009; 64:228–232.
  • Kurmi OP, Semple S, Simkahda P, et al. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax 2010; 65:221–228.
  • World Health Organization. The World Health Report: 2004: Changing History. Geneva: World Health Organization. Available from: http://www.who.int/whr/2004/en/- ( Accessed on 12th February 2012).
  • Wilkinson P, Smith KR, Davies M, et al. Public health benefits of strategies to reduce greenhouse-gas emissions: household energy. Lancet 2009; 374:1917–1929.
  • Smith KR, Mehta S, Maeusezahl-FeuzM. Indoor smoke from household solid fuels. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL (Eds.). Comparative quantification of health risks: Global and regional burden of disease due to selected major risk factors. Geneva: World Health Organization. 2004; 2:1435–1493.
  • Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax 2011; 66:232–239.
  • Pandey MR. Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39:331–336.
  • Smith KR, Mehta S. The burden of disease from indoor air pollution in developing countries: comparison of estimates. Int J Hyg Environ Health 2003; 206:279–289.
  • Chhabra SK, Chhabra P, Rajpal S, Gupta RK. Ambient air pollution and chronic respiratory morbidity in Delhi. Arch Environ Health 2001; 56:58–64.
  • Ehrlich RI, White N, Norman R, et al. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis 2004; 8:369–376.
  • Chen BH, Hong CJ, Pandey MR, Smith KR. Indoor air pollution in developing countries. World Health Stat Q 1990; 43:127–138.
  • Tan WC. Chronic obstructive pulmonary disease: Epidemiology. In: Mary IP, Chan-Yeung M, Lam WK, Zhong NS (Eds.). Respiratory Medicine—An Asian Perspective. Hong Kong: Hong Kong University Press, 2005; 61–72.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Updated 2005. Available from: http://www.goldcopd.org/uploads/users/files/GOLDWkshp05Clean.pdf ( Accessed on 20th November 2013).
  • Ramirez-Venegas A, Sansores RH, Peres-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006; 173:393–397.
  • Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 2008; 12:972–977.
  • Behera D, Jindal SK. Respiratory symptoms in Indian women using domestic cooking fuels. Chest 1991; 100:385–388.
  • Behera D, Jindal SK, Malhotra HS. Ventilatory function in nonsmoking rural Indian women using different cooking fuels. Respiration 1994; 61:89–92.
  • Dutt D, Srinivasa DK, Rotti SB, et al. Effect of indoor air pollution on the respiratory system of women using different fuels for cooking in an urban slum of Pondicherry. Natl Med J India 1996; 9:113–117.
  • Prasad R, Singh A, Garg R, Giridhar GB. Biomass fuel exposure and respiratory diseases in India. Biosci Trends 2012; 6:219–228.
  • International Institute of Population Sciences. National Family Health Survey (MCH and Family Planning): India 2005–2006. Mumbai: International Institute of Population Sciences, 2007.
  • Behera D, Dash S, Yadav SP. Carboxyhaemoglobin in women exposed to different cooking fuels. Thorax 1991; 46:344–346.
  • Smith KR. Indoor air pollution in developing countries: recommendations for research. Indoor Air 2002; 12:198–207.
  • Torres-Duque C, Maldonado D, Peres-Padilla R, et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008; 5:577–590.
  • Balakrishnan K, Sankr S, Parikh J, et al. Daily average exposures to respirable particulate matter from combustion of biomass fuels in rural households of southern India. Environ Health Perspect 2002; 110:1069–1075.
  • Balakrishnan K, Sambandam S, Ramaswamy P, et al. Exposure assessment for respirable particulates associated with household fuel use in rural districts of Andhra Pradesh, India. J Expo Anal Environ Epidemiol 2004; 14:S14–S25.
  • Sinha SN, Sambandam S, Ramaswamy P, et al. Gas chromatographic-mass spectroscopic determination of benzene in indoor air during the use of biomass fuels in cooking time. J Chromatogr A 2005; 1065:315–319.
  • Sinha SN, Kulkarni PK, Shah SH, et al. Environmental monitoring of benzene and toluene produced in indoor air due to combustion of solid biomass fuels. Sci Total Environ 2006; 357:280–287.
  • Ansari FA, Khan AH, Patel DK, et al. Indoor exposure to respirable particulate matter and particulate-phase PAHs in rural homes in North India. Environ Monit Assess 2010; 170:491–497.
  • Musthapa MS, Lohani M, Tiwari S, et al. Cytogenetic biomonitoring of Indian women cooking with biofuels: micronucleus and chromosomal aberration tests in peripheral blood lymphocytes. Environ Mol Mutagen 2004; 43:243–249.
  • Mahesh PA, Jayaraj BS, PrabhakarAK, et al. Identification of a threshold for biomass exposure index for chronic bronchitis in rural women of Mysore district, Karnataka, India. Ind J Med Res 2013; 137:87–94.
  • Gupta D, Aggarwal A, Jindal S. Pulmonary effects of passive smoking: the Indian experience. Tob Induc Dis 2002; 1:129–136.
  • Cook DG, Strachan DP. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 1999; 54:357–366.
  • Arbex MA, de Souza Conceicao GM, Cendon SP, et al. Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits. J Epidemiol Commun Health 2009; 63:777–783.
  • Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004; 351:1057–1067.
  • Gauderman WJ, Vora H, McConnell R, et al. Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 2007; 369:571–577.
  • Rojas-Martinez R, Peres-Padilla R, Olaiz-Fernandez G, et al. Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med 2007; 176:377–384.
  • Chung KF, Zhang J, Zhong N. Outdoor air pollution and respiratory health in Asia. Respirology 2011; 16:1023–1026.
  • Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 2001; 17:1024–1033.
  • Foster WM, Brown RH, Macri K, Mitchell CS. Bronchial reactivity of healthy subjects: 18-20 h postexposure to ozone. J Appl Physiol 2000; 89:1804–1810.
  • Oh SM, Kim HR, Park YJ, et al. Organic extracts of urban air pollution particulate matter (PM2.5)-induced genotoxicity and oxidative stress in human lung bronchial epithelial cells (BEAS-2B cells). Mutat Res 2011; 723:142–151.
  • Budinger GR, McKell JL, Urich D, et al. Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms. PLoS One 2011; 6:e18525.
  • Happo MS, Salonen RO, Hälinen AI, et al. Inflammation and tissue damage in mouse lung by single and repeated dosing of urban air coarse and fine particles collected from six European cities. Inhal Toxicol 2010; 22:402–416.
  • Wong CM, Thach TQ, Chau PY, et al. Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong. Res Rep Health Eff Inst 2010; (154):283–362.
  • Kakinoki, Y, Ohashi Y, Tanaka A, et al. Nitrogen dioxide compromises defence functions of the airway epithelium. Acta Otolaryngol Suppl 1998; 538:221–226.
  • World Health Organization. Outdoor air pollution database. Geneva: World Health Organization. Available from: http://www.who.int/entity/phe/health_topics/outdoorair/databases/OAP_database.xls ( Accessed on 8th July 2013).
  • Pande JN, Bhatta N, Biswas D, et al. Outdoor air pollution and emergency room visits at a hospital in Delhi. Ind J Chest Dis Allied Sci 2002; 44:13–19.
  • Kinare SG, Dave KM, Sivaraman A. Chronic obstructive pulmonary disease in urban environment of Bombay. Ind J Med Res 1988; 87:262–269.
  • Patankar AM, Trivedi PL. Monetary burden of health impacts of air pollution in Mumbai, India: Implications for public health policy. Public Health 2011; 125:157–164.
  • Chester EH, Gillespie DG, Krause FD. The prevalence of chronic obstructive pulmonary disease in chlorine gas workers. Am Rev Respir Dis 1969; 99:365–373.
  • Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:S85–91.
  • Burge PS. Occupation and chronic obstructive pulmonary disease (COPD). Eur Respir J 1994; 7:1032–1034.
  • Kumari B, KumarR, Madan VK, et al. Magnitude of pesticidal contamination in winter vegetables from Hisar, Haryana. Environ Monit Assess 2003; 87:311–318.
  • Chakraborty S, Mukherjee S, Roychoudhary S, et al. Chronic exposures to cholinesterase-inhibiting pesticides adversely affect respiratory health of agricultural workers in India. J Occup Health 2009; 51:488–497.
  • Chakrabarti B, Purkait S, Gun P, et al. Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index. Int J Chron Obstruct Pulmon Dis 2011; 6:543–549.
  • Rastogi SK, Gupta BN, Mathur N, et al. A survey of chronic bronchitis among brassware workers. Ann Occup Hyg 1992; 36:283–294.
  • Rastogi SK, Gupta BN, Mathur N, Husian T. Ventilatory dysfunction in glass bangle workers. Am J Ind Med 1990; 18:707–715.
  • Rastogi SK, Gupta BN, Husain T, et al. Respiratory symptoms and ventilatory capacity in metal polishers. Hum Exp Toxicol 1992; 11:466–472.
  • Gupta SK, Singh SK. A study on the prevalence of chronic bronchitis in workers exposed to smoke and irritant fumes in a railway workshop. Ind J Chest Dis Allied Sci 1992; 34:25–28.
  • Hegewald MJ, Crapo RO. Socioeconomic status and lung function. Chest 2007; 132:1608–1614.
  • Schunemann HJ, McCann S, Grant BJ, et al. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002; 155:463–471.
  • Lawlor DA, Ebrahim S, Smith GD. Association between self-reported childhood socioeconomic position and adult lung function: findings from the British Women's Heart and Health Study. Thorax 2004; 59:199–203.
  • Shohaimi S, Bingham S, Welch A, et al. Occupational social class, educational level and area deprivation independently predict plasma ascorbic acid concentration: a cross-sectional population based study in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Eur J Clin Nutr 2004; 58:1432–1435.
  • Kojima S, Sakakibara H, Motani S, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol 2005; 15:113–117.
  • Jain NK, Thakkar MS, Jain N, et al. Chronic obstructive pulmonary disease: Does gender really matter? Lung India 2011; 28:258–262.
  • Gupta B, Kant S, Mishra R, Verma S. Nutritional status of chronic obstructive pulmonary disease patients admitted in hospital with acute exacerbation. J Clin Med Res 2010; 2:68–74.
  • Vibhuti A, Arif E, Deepak D, et al. Correlation of oxidative status with BMI and lung function in COPD. Clin Biochem 2007; 40:958–963.
  • Menezes AM, Peres-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366:1875–1881.
  • Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000; 105:1041–1053.
  • Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126:59–65.
  • O'Byrne PM, Pedersen S, Busse WW, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006; 129:1478–1485.
  • Guha Mazumder D, Dasgupta UB, Chronic arsenic toxicity: studies in West Bengal, India. Kaohsiung J Med Sci 2011; 27:360–370.
  • Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010; 42:45–52.
  • Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010; 42:36–44.
  • Wilk JB, Chen TH, Gottlieb DJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009; 5:e1000429.
  • Serapinas D, Sitkauskiene B, Sakalauskas R. Inflammatory markers in chronic obstructive pulmonary disease patients with different alpha1 antitrypsin genotypes. Arch Med Sci 2012; 8:1053–1058.
  • Vijayasaratha K, Stockley RA. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD. Int J Chron Obstruct Pulmon Dis 2012; 7:789–796.
  • Piras, B, Ferrarotti I, Lara B, et al. Clinical phenotypes of Italian and Spanish patients with alpha1-antitrypsin deficiency. Eur Respir J 2013; 42:54–64.
  • Topic A, Stankovic M, Divac-Rankov A, et al. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Genet Test Mol Biomarkers 2012; 16:1282–1286.
  • Tuder RM, Janciauskiene SM, Petrache I. Lung disease associated with alpha1-antitrypsin deficiency. Proc Am Thorac Soc 2010;7:381–6.
  • Gupta J, Bhadoria DP, Lal MK, et al. Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease. Clin Biochem 2005; 38:489–491.
  • Shukla, RK, Kant S, Bhattacharya S, Mittal B. Association of genetic polymorphism of GSTT1, GSTM1 and GSTM3 in COPD patients in a north Indian population. COPD 2011; 8:167–172.
  • Thakur H, Gupta L, Sobti RC, et al. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep 2011; 38:1733–1739.
  • Sobti RC, Thakur H, Hupta L, et al. Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population. Mol Biol Rep 2011; 38:3137–3144.
  • Arif E, Vibhuti A, Alam P, et al. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease. Clin Chim Acta 2007; 382):37–42.
  • Vibhuti A, Arif E, Deepak D, et al. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun 2007; 359:136–142.
  • Arif E, Vibhuti A, Deepak D, et al. COX2 and p53 risk-alleles coexist in COPD. Clin Chim Acta 2008; 397:48–50.
  • Vibhuti A, Arif E, Misra A, et al. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD. Clin Chim Acta 2010; 411:474_480.
  • Kumar M, Bhadoria DP, Dutta K, et al. Combinatorial effect of TIMP-1 and alpha1AT gene polymorphisms on development of chronic obstructive pulmonary disease. Clin Biochem 2011; 44:1067–1073.
  • Malik SK. Exposure to domestic cooking fuels and chronic bronchitis. Ind J Chest Dis Allied Sci 1985; 27:171–174.
  • Qureshi KA. Domestic smoke pollution and prevalence of chronic bronchitis/asthma in a rural area of Kashmir. Ind J Chest Di Allied Sci 1994; 36:61–72.
  • Shukla, RK, Kant S, Bhattacharya S, Mittal B. Association of genetic polymorphism of GSTT1, GSTM1 and GSTM3 in COPD patients in a north Indian population. COPD 2011; 8:167–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.